EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Clinical Presentation and Immunological Characteristics of Plastic Bronchitis in Children With Severe MPP

Haojie Wang, Lang Yuan, Chao Sun, Zeyu Zeng, Xiaoyan Dong

The Clinical Respiratory Journal · 2026-11 · 20 (11)

DOI: 10.1111/crj.70232 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Plastic bronchitis (PB) complicating severe Mycoplasma pneumoniae pneumonia (SMPP) increases respiratory failure risk and worsens outcomes. However, clinical and immunological features of PB concurrent with SMPP remain incompletely understood. This study aimed to characterize clinical, immunological, and radiological features of SMPP children with PB and identify independent predictors of PB. A retrospective analysis compared clinical, immune, and imaging data between SMPP children with and without PB. Risk factors were identified and assessed for diagnostic relevance. SMPP children with PB showed prolonged fever duration, higher peak temperature, and more severe respiratory symptoms compared with children with SMPP alone. Immunological findings included decreased peripheral CD4 + /CD8 + ratio, elevated serum IgM, increased bronchoalveolar lavage fluid (BALF) monocyte percentage (M%), and elevated cytokines IL‐6, IL‐8, and IFN‐γ. Univariate and multivariate analyses identified MP resistance, number of affected lung lobes, serum IgM, CD4 + /CD8 + ratio, and BALF M% as independent predictors of PB in SMPP children. Receiver operating characteristic (ROC) analysis demonstrated that fever duration and the number of affected lung lobes showed diagnostic discrimination for PB, with their combination yielding an area under the curve (AUC) of 0.836. The CD4 + /CD8 + ratio, serum IgM level, and BALF M% showed moderate diagnostic discrimination individually, and their combined model yielded an AUC of 0.736. A comprehensive model integrating macrolide resistance, the number of affected lung lobes, CD4 + /CD8 + ratio, serum IgM level, and BALF M% achieved an AUC of 0.868. SMPP children complicated by PB exhibit significant immune dysregulation and extensive pulmonary pathology. Clinical (MP resistance and number of affected lung lobes) and immunological (IgM level, CD4 + /CD8 + ratio, and BALF M%) markers may facilitate early PB diagnosis and timely treatment.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →